Polypharmacy in psychiatric patients as an alternative to limited mental health resources;La polimedicación de los pacientes psiquiátricos como alternativa a la escasez de recursos asistenciales

Actas Espanolas de Psiquiatria

Volumn 33, Issue 2, 2005, Pages 81-86

  De Las Cuevas, C ^a,d   Sanz, E J ^a   De La Fuente, J A ^b   Cueto, M ^c  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c Servicio Canario de la Salud   (Spain)

^d NONE   (Spain)

Author keywords

Polypharmacy; Psychiatric patients; Psychotropic drugs; Single drug therapy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; EDUCATION; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL PRACTICE; MENTAL DISEASE; MULTIPLE REGRESSION; PREVALENCE; SEX RATIO; WORK CAPACITY;

EID: 17844395940     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Andreasen, NC, Black DW. Introductory textbook of psychiatry. Washington: American Psychiatric Press, 1991.
2. Schazberg AF, Nemeroff CB. The American Psychiatric Textbook of Psychopharmacology. Washington: American Psychiatric Press, 1995.
3. Gelder M, Gath D, Mayou R, Cowen, P. Oxford textbook of psychiatry. Third edition. Oxford: Oxford University Press, 1996.
4. Welch R, Snaterse M. Combination therapy: is clinical practice leading the way. Clin Psychiatry, 2003;64(1):94.
5. Preskozn SH. Polypharmacy: when is it rational? J Pract Psychiatry Behav Health 1995;1:92-8.
6. Lewis L. Reduce polypharmacy and boost appropriate drug use. J Am Med Dir Assoc 2001;2(4):36-7.
7. Mason AS. Basic principles in the use of antipsychotic agents. Hosp Community Psychiatry 1973;24:825-9.
8. Tanaka E, Hisawa S. Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharm Ther 1999;24:7-16.
9. Muir AJ, Sanders LL, Wilkinson WE, Schmader K. Reducing medication regimen complexity: a controlled trial. J Gen Intern Med 2001;16:77-82.
10. Murray MD, Kroenke K. Polypharmacy and medication adherence. Small Steps on a Long Road. J Gen Intern Med, 2001;16(2):137-9.
11. De las Cuevas C, Sanz E, de la Fuente, JA. Variations in antidepressant prescribing practice. ¿Clinical need or market influences? Pharmacoepidemiol Drug Saf 2002;11:515-22.
12. Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997;53(1):7-11.
13. NASMHPD Medical Directors. Technical report on psychiatric polypharmacy. National Association of State Mental Health Program Directors. Alexandria, Virginia, 2001.
14. Stahl, SM. Antipsychotic polypharmacy: evidence based or eminence based? Acta Psychiatr Scand 2002:106;321-2.
15. World Health Organization. International Statistical Classification of diseases and related health problems, tenth revision. Vol 1. Geneva: WHO, 1992.
16. Berube MS, Neely DJ, DeVinne, PB. American Heritage Dictionary. 2nd College ed. Boston: Houghton Mifflin Co, 1982.
17. Werder, SF, Preskorn, SH. Managing polypharmacy: walking the fine line between help and harm. Current Psychiatry Online 2003;2(2)
18. Friend DG. Polypharmacy: multiple-ingredient and shotgun prescriptions. N Engl J Med 1959;260(20):1015-8.
19. Sheppard C, Collins L, Fiorentino D, Fracchia J, Merlis S. Polypharmacy in psychiatric treatment. I. Incidence at a state hospital. Curr Ther Res Clin Exp 1969;(12):765-74.
20. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003;160(1): 4-12.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV-TR. (Fourth edition, text revision.) Washington: American Psychiatric Association, 2000.
22. Rittmannsberger H. The use of drug monotherapy in psychiatric inpatinte treatment. Progress in neuro-psycho-pharmacology and biological psychiatry 2002;26:547-51.
23. Kapur S. Polypharmacy-in-a-Pill: a scientific advance or are we making a virtue of our necessities? Med Gen Med 2001;3(2).
24. De las Cuevas C, Sanz EJ. Polypharmacy in psychiatric practice in the Canary Islands. BMC Psychiatry 2004;4:18.
25. De las Cuevas C, Sanz EJ. Do therapeutic indications of antidepressants change from one year to another? Published Online: Pharmacoepidemiol Drug Saf, 2003.
26. Harris CM, Heywood PL, Clayden AD. The Analysis of prescribing in general practice: a guide to audit and research. London: HSMO, 1990.